Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Ariad Declines After Stopping Iclusig Study on Clot Risk
Ariad Declines After Stopping Iclusig Study on Clot Risk
Ariad Declines After Stopping Iclusig Study on Clot Risk
Submitted by
admin
on October 19, 2013 - 3:43pm
Source:
Bloomberg
News Tags:
Ariad Pharmaceuticals
Iclusig
chronic myeloid leukemia
leukemia
Headline:
Ariad Declines After Stopping Iclusig Study on Clot Risk
Do Not Allow Advertisers to Use My Personal information
